Improving CAR-based-immunotherapies using a molecular anchor

Adding a molecular anchor to the key protein used to recognize cancer in cellular immunotherapies can make the treatments significantly more effective.

Related Keywords

Jorge Ibanez Vega , Lindsay Talbot , Peter Chockley , Giedre Krenciute , Stephen Gottschalk , Emily Henderson , Cancer Research Industry , Foundation For Childhood Cancer Research , National Cancer Institute , Jude Children Research Hospital , National Institutes Of Health , Cancer Research , Jude Department Of Bone Marrow Transplantation , National Institute Of Neurological Disorders , Jude Children , Research Hospital , Natural Killer , Jude Department , Bone Marrow Transplantation , Cellular Therapy , Research Industry Focus , Jude Sumara Fellowship , Chadtough Defeat , National Institute , Neurological Disorders , Rally Foundation , Childhood Cancer Research , Garwood Postdoctoral Fellowship , National Institutes , Antigen , Biotechnology , One , Bone Marrow , Dancer , Fell , Children , Chimeric Antigen Receptor , Hospital , Olecule , Mh , Protein , Eceptor , Research , Qynapse , Humor ,